Skip to main content

Monjuvi Prices, Coupons and Patient Assistance Programs

Monjuvi (tafasitamab) is a member of the CD19 monoclonal antibodies drug class and is commonly used for Diffuse Large B-Cell Lymphoma.

The cost for Monjuvi intravenous powder for injection 200 mg is around $1,331 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Monjuvi prices

Intravenous Powder For Injection

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Monjuvi Coupons, Copay Cards and Rebates

Monjuvi offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Monjuvi My Mission Support Copay Program: Eligible commercially insured patients may pay as little as $0 per prescription with a maximum savings of up to $25,000 per calendar year; for more information contact the program at 855-421-6172.

Applies to:
Monjuvi
Number of uses:
per prescription per calendar year

Form more information phone: 855-421-6172 or Visit website

Patient Assistance & Copay Programs for Monjuvi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Monjuvi (tafasitamab-cxix) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: My MISSION Support Program

Elligibility requirements:
  1. Determined case by case
  2. Varies
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US.
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Monjuvi (tafasitamab-cxix) Injection; IV

More information please phone: 855-421-6172 Visit Website